{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:34Z","timestamp":1791897814694,"version":"4.3.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0238809","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:49:36Z","timestamp":1599846576000},"page":"e0238809","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-863X","authenticated-orcid":true,"given":"Annelies","family":"Verbiest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Van Hoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodriguez-Antona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Garc\u00eda-Donas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo","family":"Gra\u00f1a-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Albersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Baldewijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sch\u00f6ffski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Wozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Couchy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Beuselinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"issue":"2","key":"pone.0238809.ref001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"DP Bartel","year":"2009","journal-title":"Cell"},{"key":"pone.0238809.ref002","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1038\/ncomms6202","article-title":"Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression","volume":"5","author":"R Rupaimoole","year":"2014","journal-title":"Nat Commun"},{"issue":"6","key":"pone.0238809.ref003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc3932","article-title":"MicroRNA biogenesis pathways in cancer","volume":"15","author":"S Lin","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"7456","key":"pone.0238809.ref004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"CJ Creighton","year":"2013","journal-title":"Nature"},{"key":"pone.0238809.ref005","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1245\/s10434-019-07578-3","article-title":"4-miRNA score predicts the individual metastatic risk of renal cell carcinoma patients","volume":"26","author":"J Heinzelmann","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"pone.0238809.ref006","doi-asserted-by":"crossref","first-page":"e86051","DOI":"10.1172\/jci.insight.86051","article-title":"Deep sequencing reveals microRNAs predictive of antiangiogenic drug response","volume":"1","author":"J Garc\u00eda-Donas","year":"2016","journal-title":"JCI Insight"},{"issue":"12","key":"pone.0238809.ref007","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1593\/neo.12734","article-title":"MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients","volume":"14","author":"A G\u00e1mez-Pozo","year":"2012","journal-title":"Neoplasia"},{"issue":"9","key":"pone.0238809.ref008","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1007\/s13277-016-5144-5","article-title":"The dual regulatory role of miR-204 in cancer","volume":"37","author":"T Li","year":"2016","journal-title":"Tumor Biol"},{"issue":"5","key":"pone.0238809.ref009","doi-asserted-by":"crossref","first-page":"e35661","DOI":"10.1371\/journal.pone.0035661","article-title":"Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis","volume":"7","author":"X Wu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"pone.0238809.ref010","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1158\/1078-0432.CCR-14-1128","article-title":"Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting","volume":"21","author":"B Beuselinck","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"4","key":"pone.0238809.ref011","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/2159-8290.CD-18-0957","article-title":"Transcriptomic profiling of the tumor microenvironment reveals distinct subgroups of clear cell renal cell cancer: data from a randomized phase III trial","volume":"9","author":"AA Hakimi","year":"2019","journal-title":"Cancer Discov"},{"issue":"1","key":"pone.0238809.ref012","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eururo.2014.02.035","article-title":"ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma","volume":"66","author":"SA Brooks","year":"2014","journal-title":"Eur Urol"},{"key":"pone.0238809.ref013","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1038\/ncomms9878","article-title":"MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes","volume":"6","author":"L Cantini","year":"2015","journal-title":"Nat Commun"},{"issue":"7492","key":"pone.0238809.ref014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","author":"JN Weinstein","year":"2014","journal-title":"Nature"},{"issue":"5","key":"pone.0238809.ref015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/embo-reports\/kvf090","article-title":"MyRIP, a novel Rab effector, enables myosin VIIa recruitment to retinal melanosomes","volume":"3","author":"A El\u2010Amraoui","year":"2002","journal-title":"EMBO Rep"},{"issue":"2","key":"pone.0238809.ref016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.eururo.2019.05.022","article-title":"Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma","volume":"76","author":"L Albiges","year":"2019","journal-title":"Eur Urol"},{"issue":"12","key":"pone.0238809.ref017","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jclinpath-2011-200216","article-title":"Sarcomatoid renal cell carcinoma is an example of epithelial-mesenchymal transition","volume":"64","author":"J Conant","year":"2011","journal-title":"J Clin Pathol"},{"issue":"4","key":"pone.0238809.ref018","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/imt.15.17","article-title":"IL-11 signaling as a therapeutic target for cancer","volume":"7","author":"TL Putoczki","year":"2015","journal-title":"Immunotherapy"},{"issue":"4","key":"pone.0238809.ref019","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ccr.2012.02.019","article-title":"VHL-Regulated miR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma","volume":"21","author":"O Mikhaylova","year":"2012","journal-title":"Cancer Cell"},{"issue":"3","key":"pone.0238809.ref020","article-title":"The miR-30 family: versatile players in breast cancer","volume":"39","author":"S-J Yang","year":"2017","journal-title":"Tumor Biol"},{"issue":"12","key":"pone.0238809.ref021","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/cas.12291","article-title":"Hypoxia\u2010induced downregulation of mi R\u201030c promotes epithelial\u2010mesenchymal transition in human renal cell carcinoma","volume":"104","author":"J Huang","year":"2013","journal-title":"Cancer Sci"},{"issue":"1","key":"pone.0238809.ref022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/2159-8290.CD-13-0291","article-title":"Restricted Expression of miR-30c-2-3p and miR-30a-3p in Clear Cell Renal Cell Carcinomas Enhances HIF2\u03b1 Activity","volume":"4","author":"LK Mathew","year":"2014","journal-title":"Cancer Discov"},{"issue":"2","key":"pone.0238809.ref023","doi-asserted-by":"crossref","first-page":"e31060","DOI":"10.1371\/journal.pone.0031060","article-title":"Up-regulation of microRNA-21 correlates with lower kidney cancer survival","volume":"7","author":"MS Zaman","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"pone.0238809.ref024","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00432-015-1927-0","article-title":"A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma","volume":"141","author":"Y-Z Ge","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"pone.0238809.ref025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2407-14-25","article-title":"Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma","volume":"14","author":"D Vergho","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"pone.0238809.ref026","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmoldx.2012.02.003","article-title":"The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma","volume":"14","author":"H Faragalla","year":"2012","journal-title":"J Mol Diagnostics"},{"issue":"6","key":"pone.0238809.ref027","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10735-013-9516-5","article-title":"Identification of miR-7 as an oncogene in renal cell carcinoma","volume":"44","author":"Z Yu","year":"2013","journal-title":"J Mol Histol"},{"issue":"11","key":"pone.0238809.ref028","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/mt.2015.129","article-title":"miR-221\/222 are involved in response to sunitinib treatment in metastatic renal cell carcinoma","volume":"23","author":"HWZ Khella","year":"2015","journal-title":"Mol Ther"},{"issue":"3","key":"pone.0238809.ref029","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"B Langmead","year":"2009","journal-title":"Genome Biol"},{"issue":"12","key":"pone.0238809.ref030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"MI Love","year":"2014","journal-title":"Genome Biol"},{"issue":"1","key":"pone.0238809.ref031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"EdgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"MD Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"18","key":"pone.0238809.ref032","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Z Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"pone.0238809.ref033","doi-asserted-by":"crossref","first-page":"e4262","DOI":"10.7717\/peerj.4262","article-title":"RBiomirGS: an all-in-one miRNA gene set analysis solution featuring target mRNA mapping and expression profile integration","volume":"6","author":"J Zhang","year":"2018","journal-title":"PeerJ"},{"issue":"1","key":"pone.0238809.ref034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B"},{"issue":"34","key":"pone.0238809.ref035","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor\u2013targeted agents: results from a large, multicenter study","volume":"27","author":"DY Heng","year":"2009","journal-title":"J Clin Oncol"},{"issue":"16","key":"pone.0238809.ref036","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"CD Johnson","year":"2007","journal-title":"Cancer Res"},{"issue":"5818","key":"pone.0238809.ref037","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1137999","article-title":"Disrupting the Pairing Between let-7 and Hmga2 enhances oncogenic transformation","volume":"315","author":"C Mayr","year":"2007","journal-title":"Science"},{"issue":"5","key":"pone.0238809.ref038","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3892\/etm.2015.2318","article-title":"microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo","volume":"9","author":"Z Zhang","year":"2015","journal-title":"Exp Ther Med"},{"issue":"5","key":"pone.0238809.ref039","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jtcvs.2015.02.012","article-title":"Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma","volume":"149","author":"J Wang","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"pone.0238809.ref040","first-page":"2175","article-title":"Oncogenic miR\u2011425\u20115p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma","volume":"16","author":"J Quan","year":"2018","journal-title":"Oncol Lett"},{"issue":"10","key":"pone.0238809.ref041","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2016-05-714535","article-title":"miR-146b antagomir\u2013treated human Tregs acquire increased GVHD inhibitory potency","volume":"128","author":"Y Lu","year":"2016","journal-title":"Blood"},{"issue":"3","key":"pone.0238809.ref042","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1159\/000493224","article-title":"Hypoxia-regulated miR-146a targets cell adhesion molecule 2 to promote proliferation, migration, and invasion of clear cell renal cell carcinoma","volume":"49","author":"L Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"pone.0238809.ref043","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"N Raver-Shapira","year":"2007","journal-title":"Mol Cell"},{"issue":"4","key":"pone.0238809.ref044","doi-asserted-by":"crossref","first-page":"e0124899","DOI":"10.1371\/journal.pone.0124899","article-title":"Increased microRNA-34b and-34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer","volume":"10","author":"Y Hiyoshi","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"pone.0238809.ref045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microRNA for detecting breast cancer in the early stage","volume":"107","author":"A Shimomura","year":"2016","journal-title":"Cancer Sci"},{"issue":"20","key":"pone.0238809.ref046","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1016\/j.febslet.2012.09.016","article-title":"miR\u2010134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non\u2010small cell lung cancer cells","volume":"586","author":"J Li","year":"2012","journal-title":"FEBS Lett"},{"issue":"2","key":"pone.0238809.ref047","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.febslet.2014.12.002","article-title":"MicroRNA\u2010134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins","volume":"589","author":"Y Gao","year":"2015","journal-title":"FEBS Lett"},{"issue":"3","key":"pone.0238809.ref048","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/cas.12072","article-title":"Tumor\u2010suppressive micro RNA\u2010135a inhibits cancer cell proliferation by targeting the c\u2010MYC oncogene in renal cell carcinoma","volume":"104","author":"Y Yamada","year":"2013","journal-title":"Cancer Sci"},{"key":"pone.0238809.ref049","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopha.2016.09.074","article-title":"miRNA-133b and miRNA-135a induce apoptosis via the JAK2\/STAT3 signaling pathway in human renal carcinoma cells","volume":"84","author":"W Zhou","year":"2016","journal-title":"Biomed Pharmacother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T17:49:44Z","timestamp":1723571384000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0238809"}},"subtitle":[],"editor":[{"given":"Olorunseun","family":"Ogunwobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0238809","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]}}}